002734.SHE Limin Chemical Co Ltd
- Market cap
- CNY 5.49B
- P/E
- 17.1x
- P/B
- 1.33x
- ROE
- 7.3%
- Dividend yield
- 2.56%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002734.SHE undervalued?
Graham number002734.SHE trades 0.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Limin Chemical Co Ltd fundamental analysis
No fundamental analysis for Limin Chemical Co Ltd yet.
Limin Chemical Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Limin Chemical Co Ltd
Limin Group Co.,Ltd. engages in the research and development, production, and sale of fungicides, insecticides, and herbicides in China. The company offers technical, single formulation, and mixture of fungicide, insecticide, herbicide, nematicide, and acaricide. It also provides veterinary drugs, including Azoxystrobin 97% TC, Captan 95% TC, Chlorothalonil 98% TC, Cymoxanil 98% TC, Cyprodinil 95% TC, Difenoconazole 95% TC, Famoxadone 98% TC, Folpet 95% TC, Fosetyl-al 96% TC…
Full company profileLimin Chemical Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Limin Chemical Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.16B | 1.42B | 1.52B | 2.83B | 4.39B | 4.74B | 5.02B | 4.22B | 4.24B | 4.53B | 4.35B |
| Gross Profit | 334M | 390M | 408M | 741M | 1.06B | 1.05B | 925M | 682M | 757M | 1.20B | 1.04B |
| Operating Income | 138M | 163M | 232M | 354M | 494M | 379M | 259M | 64.3M | 114M | 597M | 472M |
| EBITDA | 190M | 237M | 248M | 366M | 671M | 670M | 542M | 471M | 511M | 1.03B | 394M |
| Net Income | 113M | 137M | 206M | 322M | 386M | 307M | 219M | 62.1M | 81.4M | 480M | 288M |
| EPS | 0.38 | 0.38 | 0.57 | 0.89 | 1.05 | 0.82 | 0.59 | 0.17 | 0.22 | 1.01 | 0.61 |
| Balance Sheet | |||||||||||
| Total Assets | 2.08B | 2.39B | 2.74B | 4.77B | 5.19B | 6.88B | 7.06B | 6.82B | 6.66B | 6.59B | 6.84B |
| Total Liabilities | 488M | 656M | 858M | 2.47B | 2.67B | 4.00B | 4.22B | 4.00B | 3.96B | 2.55B | 2.77B |
| Shareholders' Equity | 1.59B | 1.67B | 1.82B | 2.07B | 2.37B | 2.70B | 2.80B | 2.77B | 2.64B | 3.96B | 3.97B |
| Cash & Short-term Investments | 676M | 384M | 360M | 447M | 733M | 1.09B | 771M | 817M | 771M | 769M | 1.06B |
| Total Debt | 230M | 361M | 565M | 1.04B | 1.05B | 2.17B | 2.21B | 1.93B | 2.00B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 259M | 73.1M | 232M | 197M | 903M | 59.6M | 643M | 471M | 374M | 533M | - |
| Capital Expenditure | 219M | 144M | 177M | 378M | 349M | 1.04B | 735M | 237M | 98.0M | 86.9M | 62.7M |
| Free Cash Flow | 39.9M | -70.5M | 54.5M | -181M | 554M | -985M | -92.1M | 234M | 276M | 446M | 141M |
| Ratios | |||||||||||
| ROE | 7.1% | 8.2% | 11.3% | 15.5% | 16.3% | 11.4% | 7.8% | 2.2% | 3.1% | 12.1% | 7.3% |
| ROA | 5.4% | 5.8% | 7.5% | 6.8% | 7.4% | 4.5% | 3.1% | 0.9% | 1.2% | 7.3% | 4.2% |
| Net Profit Margin | 9.7% | 9.6% | 13.6% | 11.4% | 8.8% | 6.5% | 4.4% | 1.5% | 1.9% | 10.6% | 6.6% |
| Debt to Equity | 0.14x | 0.22x | 0.31x | 0.50x | 0.44x | 0.80x | 0.79x | 0.70x | 0.76x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Limin Chemical Co Ltd dividends
- Dividend yield
- 2.56%
- Forward dividend
- 0.45 CNY
- Payout ratio
- 29.3%
- Ex-dividend date
- May 22, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 140M | 0.30 | 29.3% |
| 2024 | CNY 159M | 0.43 | 195.6% |
| 2023 | CNY 137M | 0.37 | 220.5% |
| 2022 | CNY 110M | 0.30 | 50.4% |
| 2021 | CNY 93.1M | 0.25 | 30.3% |
| 2020 | CNY 86.0M | 0.23 | 22.3% |
| 2019 | CNY 99.2M | 0.27 | 30.8% |
| 2018 | CNY 100M | 0.28 | 48.7% |
| 2017 | CNY 74.7M | 0.20 | 54.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.3:1 on May 26, 2020.
Who owns Limin Chemical Co Ltd
- Insiders 28.98%
- Institutions 2.83%
- Public & others 68.20%
- Shares outstanding 472M
- Free float 342M
Limin Chemical Co Ltd company profile
- Company name
- Limin Chemical Co Ltd
- Ticker
- 002734.SHE
- ISIN
- CNE100001WQ3
- Exchange
- Shenzhen Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 4,593
- Fiscal year end
- December
- Address
- Xinyi Economic Development Zone, Xuzhou, China, 221400
- Phone
- 86 516 8898 4586
- Website
- chinalimin.com
About Limin Chemical Co Ltd
Limin Group Co.,Ltd. engages in the research and development, production, and sale of fungicides, insecticides, and herbicides in China. The company offers technical, single formulation, and mixture of fungicide, insecticide, herbicide, nematicide, and acaricide. It also provides veterinary drugs, including Azoxystrobin 97% TC, Captan 95% TC, Chlorothalonil 98% TC, Cymoxanil 98% TC, Cyprodinil 95% TC, Difenoconazole 95% TC, Famoxadone 98% TC, Folpet 95% TC, Fosetyl-al 96% TC, Mancozeb 88% TC, Mancozeb 96% TC, Metiram 85% TC, Metiram 87% TC, Metiram 87% TC, Propineb 89% TC, Pyraclostrobin 97.5% TC, Pyraclostrobin 98% TC, Pyrimethanil 95% TC, Trifloxystrobin 97% TC, and Zineb 90% TC. The company was formerly known as Limin Chemical Co., Ltd. and changed its name to Limin Group Co.,Ltd. in January 2020. Limin Group Co.,Ltd. was founded in 1996 and is based in Xuzhou, China.
Limin Chemical Co Ltd management
5- Mr. Chaohui FanPresident & Director · born 1968
- Ms. Shuyan ShenCFO & VP · born 1966
- Mr. Jingquan SunChief Engineer & Director · born 1964
- Mr. Hao WuSecretary to the Board · born 1988
- Yanli HouAccounting Supervisor